BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21519239)

  • 1. Red blood cells from induced pluripotent stem cells: hurdles and developments.
    Mazurier C; Douay L; Lapillonne H
    Curr Opin Hematol; 2011 Jul; 18(4):249-53. PubMed ID: 21519239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Red blood cell production for transfusion purposes. A stem cell ex vivo fate].
    Mazurier C; Douay L
    Transfus Clin Biol; 2013 May; 20(2):90-4. PubMed ID: 23601197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion?
    Douay L; Andreu G
    Transfus Med Rev; 2007 Apr; 21(2):91-100. PubMed ID: 17397760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells: will they be safe?
    Jalving M; Schepers H
    Curr Opin Mol Ther; 2009 Aug; 11(4):383-93. PubMed ID: 19649983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges.
    Peyrard T; Bardiaux L; Krause C; Kobari L; Lapillonne H; Andreu G; Douay L
    Transfus Med Rev; 2011 Jul; 25(3):206-16. PubMed ID: 21377319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced human pluripotent stem cells: promises and open questions.
    Rolletschek A; Wobus AM
    Biol Chem; 2009 Sep; 390(9):845-9. PubMed ID: 19558327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells.
    Baek EJ; Kim HS; Kim S; Jin H; Choi TY; Kim HO
    Transfusion; 2008 Oct; 48(10):2235-45. PubMed ID: 18673341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From stem cells to red blood cells: how far away from the clinical application?
    Xie X; Li Y; Pei X
    Sci China Life Sci; 2014 Jun; 57(6):581-5. PubMed ID: 24829108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of human induced pluripotent stem cells.
    Ohnuki M; Takahashi K; Yamanaka S
    Curr Protoc Stem Cell Biol; 2009 Jun; Chapter 4():Unit 4A.2. PubMed ID: 19536759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promise of human induced pluripotent stem cells for research and therapy.
    Nishikawa S; Goldstein RA; Nierras CR
    Nat Rev Mol Cell Biol; 2008 Sep; 9(9):725-9. PubMed ID: 18698329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro production of red blood cells.
    Mountford JC; Turner M
    Transfus Apher Sci; 2011 Aug; 45(1):85-9. PubMed ID: 21723197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for the manufacture of red cells for transfusion.
    Mountford J; Olivier E; Turner M
    Br J Haematol; 2010 Apr; 149(1):22-34. PubMed ID: 20151974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of pluripotency in human cord blood unrestricted somatic stem cells.
    Zaehres H; Kögler G; Arauzo-Bravo MJ; Bleidissel M; Santourlidis S; Weinhold S; Greber B; Kim JB; Buchheiser A; Liedtke S; Eilken HM; Graffmann N; Zhao X; Meyer J; Reinhardt P; Burr B; Waclawczyk S; Ortmeier C; Uhrberg M; Schöler HR; Cantz T; Wernet P
    Exp Hematol; 2010 Sep; 38(9):809-18, 818.e1-2. PubMed ID: 20541586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies toward CNS-regeneration using induced pluripotent stem cells.
    Okano H
    Genome Inform; 2009 Oct; 23(1):217-20. PubMed ID: 20180278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
    Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
    Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.
    Lei F; Zhao B; Haque R; Xiong X; Budgeon L; Christensen ND; Wu Y; Song J
    Cancer Res; 2011 Jul; 71(14):4742-7. PubMed ID: 21628492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of human induced pluripotent stem cells from a Bombay individual: moving towards "universal-donor" red blood cells.
    Seifinejad A; Taei A; Totonchi M; Vazirinasab H; Hassani SN; Aghdami N; Shahbazi E; Yazdi RS; Salekdeh GH; Baharvand H
    Biochem Biophys Res Commun; 2010 Jan; 391(1):329-34. PubMed ID: 19912985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of murine embryonic stem and induced pluripotent stem cells to renal lineage in vitro.
    Morizane R; Monkawa T; Itoh H
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1334-9. PubMed ID: 19883625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.